AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Coniglu G 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Coniak Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Coniglu G 2mg/500mg Tablet SR

GlucoTwin 2mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by regulating blood glucose. Administer GlucoTwin with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney damage, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are essential to mitigate this risk. Alcohol consumption should be avoided due to increased hypoglycemia risk. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require physician consultation before use. Regular blood glucose monitoring and periodic blood tests (blood counts, liver function) are recommended.

Primary Ingredients of Coniglu G 2mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Coniglu G 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Coniglu G 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Coniglu G 2mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this extended-release tablet with a meal.

Common Side effects of Coniglu G 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Coniglu G 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Coniglu G 2mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.

How Coniglu G 2mg/500mg Tablet SR works:

Coniglu G SR tablets (2mg/500mg) combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Coniglu G 2mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Coniglu G 2mg/500mg SR tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Coniglu G 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving may result from abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Coniglu G 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Coniglu G 2mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Coniglu G 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Coniglu G 2mg/500mg Tablet SR :

Should you forget a Coniglu G 2mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Coniglu G 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Coniglu G 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Coniglu G 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Coniglu G 2mg/500mg Tablet SR and seek immediate medical attention.
Coniglu G 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Coniglu G 2mg/500mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Coniglu G 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Coniglu G 2mg/500mg Tablet SR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Coniglu G 2mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Coniglu G 2mg/500mg Table...
51
MRP 59
13% off